Rockwell Medical Technologies (RMTI) renewed its distribution agreement with Nipro Medical for another three years. Rockwell Medical focuses on the development and commercialization …
Is more volatility on tap for stocks? Following a three-week losing streak, the longest in about a year, all eyes are on the …
To buy or not to buy, that’s the question. For even the most seasoned Wall Street observers, determining the ideal time to pull …
Tazeen Ahmad at Merrill Lynch, one of Wall Street’s best performing analysts, is out with newly bullish insights on ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) while …
Rockwell Medical Inc (NASDAQ:RMTI) reported results for the third quarter of 2016. Q3 2016 Financial Highlights Sales were $12.
Rockwell Medical Inc (NASDAQ:RMTI) announced that the Triferic Phase-1 Healthy Volunteer Intravenous (IV) Pharmacokinetic Study has been published in the Journal of Clinical Pharmacology. Triferic …
Rockwell Medical Inc (NASDAQ:RMTI) provided an update on the commercial launch of Calcitriol, stating that stability data for completed finished product for commercial …
Rockwell Medical Inc (NASDAQ:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for …